MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ALEC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alector (ALEC) Ownership - Who owns Alector?

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
131 Oyster Point Boulevard
Phone
+1 415 231-5660
Employees
103
Web
https://www.alector.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
197.62M
P/E Ratio
N/A
Total Cash
206.52M
Projected Growth
N/A
Total Debt
34.55M
Revenue
18.42M
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash/Share
1.86
Total Debt/Equity
N/A
Revenue/Share
0.17 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ALEC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ALEC
A.I. Advisor
published General Information

General Information

a developer of therapeutics for Alzheimer's disease and other neurodegenerative disorders

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
131 Oyster Point Boulevard
Phone
+1 415 231-5660
Employees
103
Web
https://www.alector.com